FDA acts against unapproved colchicine

Feb 06, 2008

The U.S. Food and Drug Administration said it will take action against companies marketing unapproved injectable colchicine, a drug used to treat gout.

Colchicine is a highly toxic drug that can easily be administered in excessive doses, especially when given intravenously, the FDA said, noting there's only a narrow margin between an effective dose of the drug and a toxic, perhaps even fatal, dose.

Officials said they had received 50 reports of adverse events associated with the use of intravenous colchicine, including 23 deaths.

"Today's action supports our ongoing efforts to end the marketing of unapproved drugs with serious health risks," said Dr. Janet Woodcock, the FDA's deputy commissioner for scientific and medical programs. "It is a priority that these products be removed from the market."

The FDA warned individuals and companies making the products to cease their activities within 30 days and stop shipping the product within 180 days or face regulatory action. Thereafter, all injectable colchicine drug products must have FDA approval to be manufactured or shipped interstate.

The FDA said its action announced Thursday does not affect colchicine products that are dispensed in tablet form and are frequently used to prevent gout attacks.

Copyright 2008 by United Press International

Explore further: Infectious disease experts weigh in on the creation of a human vaccine to protect against Ebola

add to favorites email to friend print save as pdf

Related Stories

Top South America hackers rattle Peru's Cabinet

39 minutes ago

The Peruvian hackers have broken into military, police, and other sensitive government networks in Argentina, Colombia, Chile, Venezuela and Peru, defacing websites and extracting sensitive data to strut ...

Great Barrier Reef dredge dumping plan could be shelved

49 minutes ago

An India-backed mining consortium could shelve controversial plans to dump dredging waste in the Great Barrier Reef, with alternative sites on land being considered amid growing environmental concerns, Australia ...

Single laser stops molecular tumbling motion instantly

29 minutes ago

In the quantum world, making the simple atom behave is one thing, but making the more complex molecule behave is another story. Now Northwestern University scientists have figured out an elegant way to stop a molecule from ...

Recommended for you

Novartis Japan admits concealing drug side effects

Sep 01, 2014

The Japanese unit of Swiss pharma giant Novartis has admitted it did not report more than 2,500 cases of serious side effects in patients using its leukaemia and other cancer drugs, reportedly including some fatalities.

Most US babies get their vaccines, CDC says

Aug 28, 2014

(HealthDay)—The vast majority of American babies are getting the vaccines they need to protect them from serious illnesses, federal health officials said Thursday.

Expression of privilege in vaccine refusal

Aug 27, 2014

Not all students returning to school this month will be up to date on their vaccinations. A new study conducted by Jennifer Reich, a researcher at the University of Colorado Denver, shows that the reasons why children may ...

User comments : 0